Off-label Use of Drugs in Childhood Asthma
European Respiratory & Pulmonary Diseases · 2015
DOI: 10.17925/erpd.2015.01.01.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory & Pulmonary Diseases, 2015. Verfasst von António J Cabral und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Asthma is among the most common illnesses in childhood and may require off-label drug use for adequate symptom control. Several studies have assessed that this use is common mainly due to a lack of clinical research. The leading concerns are the increased risk of adverse drug reactions and prescription errors. However, off-label prescriptions are not necessarily incorrect. The European Medicines Agency released the Paediatric Regulation to promote research in the medicines for children; yet, recent data suggest only a minor impact.
Zitieren
APA
Cabral, A. J., & Morais-Almeida, M. (2015). Off-label Use of Drugs in Childhood Asthma. European Respiratory & Pulmonary Diseases. https://doi.org/10.17925/erpd.2015.01.01.16
Vancouver
Cabral AJ, Morais-Almeida M. Off-label Use of Drugs in Childhood Asthma. European Respiratory & Pulmonary Diseases. 2015. doi:10.17925/erpd.2015.01.01.16
BibTeX
@article{Cabral2015,
author = {Cabral, António J and Morais-Almeida, Mário},
title = {Off-label Use of Drugs in Childhood Asthma},
journal = {European Respiratory & Pulmonary Diseases},
year = {2015},
doi = {10.17925/erpd.2015.01.01.16}
}
EUVIMED